Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma
Status:
Terminated
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The number of melanoma cases has been steadily increasing over the past few decades. For many
patients with metastatic melanoma, there are no effective therapies. The goal of this study
is to determine whether a combination drug treatment of carboplatin, paclitaxel and
temozolomide is effective in the treatment of metastatic or recurrent melanoma.